PAWC
P.A.W. Capital Portfolio holdings
AUM
$51.9M
1-Year Return
46.14%
This Quarter Return
-7.19%
1 Year Return
+46.14%
3 Year Return
+74.13%
5 Year Return
+167.35%
10 Year Return
+839.74%
AUM
$79.7M
AUM Growth
-$13.1M
(-14%)
Cap. Flow
-$3.58M
Cap. Flow
% of AUM
-4.49%
Top 10 Holdings %
Top 10 Hldgs %
43.87%
Holding
69
New
4
Increased
16
Reduced
25
Closed
6
Top Buys
| 1 |
VRTU
Virtusa Corporation
VRTU
|
$2.13M |
| 2 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$1.88M |
| 3 |
Cantaloupe
CTLP
|
$665K |
| 4 |
JPMorgan Chase
JPM
|
$586K |
| 5 |
Microsoft
MSFT
|
$508K |
Top Sells
| 1 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
$1.46M |
| 2 |
CLLS
Cellectis
CLLS
|
$1.13M |
| 3 |
CARB
Carbonite Inc
CARB
|
$1.01M |
| 4 |
Ares Capital
ARCC
|
$935K |
| 5 |
BlackRock TCP Capital
TCPC
|
$913K |
Sector Composition
| 1 | Technology | 36.8% |
| 2 | Healthcare | 16.8% |
| 3 | Communication Services | 14.15% |
| 4 | Consumer Staples | 10.92% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AT&T
T
$212B
| $714K | 0.9% |
33,100
| – | – |
|
27
Exicure
XCUR
$31.6M
| $708K | 0.89% |
1,333
| – | – |
|
|
28
Cantaloupe
CTLP
$795M
| $700K | 0.88% |
180,000
+170,945
| +1,888% | +$665K |
|
|
RDS.A
29
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $699K | 0.88% |
12,000
| – | – |
|
30
Merck
MRK
$210B
| $688K | 0.86% |
9,432
-1,048
| -10% | -$76.4K |
|
31
Verizon
VZ
$186B
| $675K | 0.85% |
12,000
-3,000
| -20% | -$169K |
|
32
PepsiCo
PEP
$201B
| $663K | 0.83% |
6,000
| – | – |
|
33
Pfizer
PFE
$140B
| $655K | 0.82% |
15,810
-1,054
| -6% | -$43.7K |
|
34
Abbott
ABT
$231B
| $651K | 0.82% |
9,000
-1,000
| -10% | -$72.3K |
|
35
Johnson & Johnson
JNJ
$431B
| $645K | 0.81% |
5,000
-500
| -9% | -$64.5K |
|
36
Procter & Gamble
PG
$373B
| $643K | 0.81% |
7,000
-1,000
| -13% | -$91.9K |
|
37
DuPont de Nemours
DD
$32.3B
| $642K | 0.81% |
5,948
+991
| +20% | +$107K |
|
|
38
Ares Capital
ARCC
$15.8B
| $623K | 0.78% |
40,000
-60,000
| -60% | -$935K |
|
39
Coca-Cola
KO
$294B
| $616K | 0.77% |
13,000
-2,000
| -13% | -$94.8K |
|
40
Galmed Pharmaceuticals
GLMD
$7.01M
| $615K | 0.77% |
500
| – | – |
|
41
GSK
GSK
$79.8B
| $611K | 0.77% |
12,800
| – | – |
|
42
BP
BP
$88.4B
| $607K | 0.76% |
16,508
+798
| +5% | +$29.3K |
|
43
AbbVie
ABBV
$376B
| $599K | 0.75% |
6,500
| – | – |
|
44
Chevron
CVX
$318B
| $598K | 0.75% |
5,500
+500
| +10% | +$54.4K |
|
45
Omega Healthcare
OHI
$12.6B
| $598K | 0.75% |
17,000
-3,000
| -15% | -$106K |
|
46
Altria Group
MO
$112B
| $593K | 0.74% |
12,000
| – | – |
|
|
47
BlackRock TCP Capital
TCPC
$611M
| $587K | 0.74% |
45,000
-70,000
| -61% | -$913K |
|
|
48
JPMorgan Chase
JPM
$835B
| $586K | 0.73% |
+6,000
| New | +$586K |
|
49
Kraft Heinz
KHC
$31.9B
| $560K | 0.7% |
13,000
+3,000
| +30% | +$129K |
|
50
Exxon Mobil
XOM
$479B
| $546K | 0.68% |
8,000
+500
| +7% | +$34.1K |
|